Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 828-229-9 | CAS number: 7019-19-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15-19 January 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- This is a Klimisch 1 OECD 439 guideline study conducted on the registered substance 1-hydroxyoctan-2-one in accordance GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 1-hydroxyoctan-2-one
- Cas Number:
- 7019-19-4
- Molecular formula:
- C8H16O2
- IUPAC Name:
- 1-hydroxyoctan-2-one
- Test material form:
- liquid
- Details on test material:
- Batch 1203/16/100
Constituent 1
- Specific details on test material used for the study:
- Batch 1081-67E
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- Initially the predictive capacity of the modified EpiDerm'M Skin Irrit ation Test (SIT) test method, using MatTek EpiDerm™ tissue model EPI-200, underwent full prospective validation from 2003-2007. The test method components of this method were used to define the essential test methods components of the original and updated ECVAM Performance Standards (PS).
A modification of the original EpiDerm'M SIT was validated using the original ECVAM PS in 2008. In 2008, ESAC concluded that the Modified EpiDerm'M SIT has sufficient accuracy and reliability for prediction of R38 skin irritating and no-label (non-skin irritating) test substances. - Vehicle:
- unchanged (no vehicle)
- Details on test system:
- The reconstructed human epidermal model EpiDermTM (EPI-200-MatTek Corporation) consists of normal human-derived epidermal keratinocytes which have been cultured to form a multi-layered highly differentiated model of the human epidermis. It consists of organised basal, spinous and granular layers and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo.
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- A single topical application of 30 µl of neat test item, negative control (DPBS) or positive control (SDS 5%) was applied to the surface of EpiDerm™ model
- Duration of treatment / exposure:
- 60 ± 1 minute (25 minutes at room temperature and 35 minutes at 37"C, 5% C02, ≥95% RH)
- Duration of post-treatment incubation (if applicable):
- 42 ± 4h post-treatment incubation, prior to the MTT endpoint
- Number of replicates:
- Three tissues per condition (Negative Control, Positive Control and Test Item)
Results and discussion
In vitro
Resultsopen allclose all
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- Corrected for freeze killed control tissues
- Run / experiment:
- 1
- Value:
- 4.834
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- Uncorrected for freeze killed control tissue
- Run / experiment:
- 1
- Value:
- 8.946
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- The viability of the MTT Interference Control (Freeze Killed Tissues) was 4.112%. Therefore, this value was subtracted from the uncorrected result of 8.946 %viability to yield the corrected result of 4.834% viability.
Any other information on results incl. tables
Viability measurements after 60 min (± 1min) of application and 42h (± 4h) post-incubation of test and reference items and controls.
Condition |
Tissue # |
Raw data |
Blank corrected data |
Mean OD |
% of Viability |
||
Aliquot 1 |
Aliquot 2 |
Aliquot 1 |
Aliquot 2 |
||||
NC |
Tissue 1 |
1.767 |
1.749 |
1.611 |
1.593 |
1.602 |
106.681 |
Tissue 2 |
1.556 |
1.55 |
1.400 |
1.394 |
1.397 |
93.030 |
|
Tissue 3 |
1.662 |
1.662 |
1.506 |
1.506 |
1.506 |
100.289 |
|
PC |
Tissue 1 |
0.258 |
0.238 |
0.102 |
0.082 |
0.092 |
6.127 |
Tissue 2 |
0.21 |
0.217 |
0.054 |
0.061 |
0.058 |
3.829 |
|
Tissue 3 |
0.2 |
0.209 |
0.044 |
0.053 |
0.049 |
3.230 |
|
TA1 |
Tissue 1 |
0.274 |
0.264 |
0.118 |
0.108 |
0.113 |
7.525 |
Tissue 2 |
0.311 |
0.31 |
0.155 |
0.154 |
0.155 |
10.289 |
|
Tissue 3 |
0.291 |
0.292 |
0.135 |
0.136 |
0.136 |
9.023 |
NC: negative control (DPBS), PC: Positive control (SDS 5%), TA1: Test Item
Mean and SD of cell viability measurements and of viability percentages after 60 min (± 1min) of application and 42h (± 4h) post-incubation.
Name |
Code |
Mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
DPBS |
NC |
1.502 |
0.103 |
100.000 |
6.830 |
6.830 |
Non-Irritant |
SDS 5% |
PC |
0.066 |
0.023 |
4.395 |
1.529 |
34.791 |
Irritant |
EXPINN PC17032 |
TA1 |
0.134 |
0.021 |
8.946 |
1.383 |
15.465 |
Irritant |
NC: Negative control (DPBS), PC: Positive control (SDS 5%), TA1: Test Item.
Prediction model of irritancy: test items that reduce the viability to 50% or below are irritant (I), test items with a percentage viability above 50% are considered to be non-irritant (NI).
Mean % viabilities obtained from additional tests to correct for MTT interference.
Test Item |
MTT Interference Control (FK): % viability |
Initial % Viability |
Corrected % Viability |
TA1 |
4.112 |
8.946 |
4.834 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- The percentage of viability obtained with the test item was 4.834%, therefore it was considered as Irritant to the skin.
- Executive summary:
In vitro assessment of the skin irritation potential of 1 -hydroxyoctan-2 -one was performed according to OECD guideline TG439:In vitroSkin Irritation: Reconstructed Human Epidermis (RHE) Test Method.This in vitro assay predicts the skin irritation potential of a chemical by measurement of its cytotoxic effect on the EpiDerm™ tissue model.The test item is applied directly to the skin surface, providing a good model of “real life” exposure. Cell viability is measured by enzymatic conversion of the vital dye MTT into a blue formazan salt that is quantitatively measured after extraction from the skin tissues. Irritant test items are identified by their ability to decrease cell viability below defined threshold levels (below or equal to 50% for UN GHS Category 2). If the viability is greater than 50%, the test item is classified as Non-Irritant (no-label).
Prior to the execution of the study, the required compatibility checks confirmed that the test item interfered with MTT. Therefore, additional freeze killed tissues were included in order to determine if any direct reduction of MTT had taken place during the main study. No water colouration was observed.
The percentage of viability obtained with the test item 1 -hydroxyoctan-2 –one was 4.834%, therefore it was considered as Irritating to the skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
